Guidelines for the management of castrate-resistant prostate cancer

Tekijä Saad, Fred, Hotte, Sebastien J.
Julkaistu 2010

Localized prostate cancer

Tekijä Kapoor, Anil, Hotte, Sebastien J.
Julkaisussa Can Urol Assoc J (2016)

Chemotherapy research for metastatic prostate cancer

Tekijä Kapoor, Anil, Hotte, Sebastien J.
Julkaisussa Can Urol Assoc J (2016)

Radionuclides

Tekijä Kapoor, Anil, Hotte, Sebastien J.
Julkaisussa Can Urol Assoc J (2016)

Androgen receptor axis-targeted agents

Tekijä Kapoor, Anil, Hotte, Sebastien J.
Julkaisussa Can Urol Assoc J (2016)

Current status of cytokine therapy in management of patients with metastatic renal cell carcinoma

Tekijä Kapoor, Anil K, Hotte, Sébastien J
Julkaistu 2007

Systemic therapy for patients with advanced, unresectable ormetastatic renal cell carcinoma: moving to guidelines

Tekijä Hotte, Sébastien J, Kapoor, Anil K
Julkaistu 2007

Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report

Tekijä Chandhoke, Gursimran, Shayegan, Bobby, Hotte, Sebastien J.
Julkaisussa J Med Case Rep (2018)

Treatment of adult rhabdoid renal cell carcinoma with sorafenib

Tekijä Kapoor, Anil, Tutino, Robert, Kanaroglou, Androniki, Hotte, Sebastien J.
Julkaistu 2008

Stereotactic Body Radiation Therapy (SBRT) for a Patient with a Myocardial Metastasis: A Case Report

Tekijä Dhar, Aneesh, Donovan, Elysia, Leong, Darryl, Hotte, Sebastien J., Swaminath, Anand
Julkaisussa Curr Oncol (2021)

Cytokines and cell adhesion molecules exhibit distinct profiles in health, ovarian cancer, and breast cancer

Tekijä Henderson, Matthew P.A., Hirte, Holger, Hotte, Sebastien J., Kavsak, Peter A.
Julkaisussa Heliyon (2016)

High-Dose Chemotherapy Followed by Peripheral and/or Bone Marrow Stem Cell Transplant in Patients With Advanced Sarcoma: Experience of a Canadian Centre

Tekijä Hotte, Sébastien J., Smith, Anne M., Bramwell, Vivien H.C., Howson-Jan, Kang
Julkaistu 2004

Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report

Tekijä Bondy, Suraya, Tajzler, Camilla, Hotte, Sebastien J., Kapoor, Anil, Zbuk, Kevin, Lalani, Aly-Khan A.
Julkaisussa Curr Oncol (2020)

The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC)

Tekijä Saad, Fred, Chi, Kim N., Finelli, Antonio, Hotte, Sebastien J., Izawa, Jonathan, Kapoor, Anil, Kassouf, Wassim, Loblaw, Andrew, North, Scott, Rendon, Ricardo, So, Alan, Usmani, Nawaid, Vigneault, Eric, Fleshner, Neil E.
Julkaisussa Can Urol Assoc J (2015)

Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces

Tekijä Woon, Dixon T.S., Chandrasekar, Thenappan, Aaron, Lorne, Basappa, Naveen S., Chi, Kim N., Conter, Henry J., Gotto, Geoffrey, Hotte, Sebastien J., Malone, Shawn, Saad, Fred, Shayegan, Bobby, Park-Wyllie, Laura, Hamilton, Robert J.
Julkaisussa Can Urol Assoc J (2018)

Management algorithms for metastatic prostate cancer

Tekijä Malone, Shawn, Shayegan, Bobby, Basappa, Naveen S., Chi, Kim, Conter, Henry J., Hamilton, Robert J., Hotte, Sebastien J., Saad, Fred, So, Alan I., Park-Wyllie, Laura, Hew, Huong, McLeod, Deanna, Gotto, Geoffrey
Julkaisussa Can Urol Assoc J (2020)

A Canadian framework for managing prostate cancer during the COVID-19 pandemic: Recommendations from the Canadian Urologic Oncology Group and the Canadian Urological Association

Tekijä Kokorovic, Andrea, So, Alan I., Hotte, Sebastien J., Black, Peter C., Danielson, Brita, Emmenegger, Urban, Finelli, Antonio, Niazi, Tamim, Pouliot, Frederic, Shayegan, Bobby, Sridhar, Srikala, Vigneault, Eric, Loblaw, Andrew, Rendon, Ricardo A.
Julkaisussa Can Urol Assoc J (2020)

Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer

Tekijä Nguyen, Eric K., Yu, Hang, Pond, Gregory, Shayegan, Bobby, Pinthus, Jehonathan H., Kapoor, Anil, Mukherjee, Som D., Neville, Alan, Lalani, Aly-Khan A., Hotte, Sebastien J., Corbett, Thomas B., Dayes, Ian S., Lukka, Himanshu R.
Julkaisussa Can Urol Assoc J (2020)

Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib

Tekijä Richter, Suzanne, Seah, Jo-An, Pond, Gregory R., Gan, Hui K., Mackenzie, Mary J., Hotte, Sebastien J., Mukherjee, Som D., Murray, Nevin, Kollmannsberger, Christian, Heng, Daniel, Haider, Masoom A., Halford, Robert, Ivy, S. Percy, Moore, Malcolm J., Sridhar, Srikala. S.
Julkaisussa Can Urol Assoc J (2014)

A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients

Tekijä Spreafico, Anna, Chi, Kim N., Sridhar, Srikala S., Smith, David C., Carducci, Michael A., Kavsak, Peter, Wong, Tracy S., Wang, Lisa, Ivy, S. Percy, Mukherjee, Som Dave, Kollmannsberger, Christian K., Sukhai, Mahadeo A., Takebe, Naoko, Kamel-Reid, Suzanne, Siu, Lillian L., Hotte, Sebastien J.
Julkaisussa Invest New Drugs (2014)